Southern Ohio Medical Center is a 222-bed 501not-for-profit hospital in Portsmouth, Ohio, providing emergency and surgical care, as well as a wide range of other health care services.

During the past decade, Southern Ohio Medical Center conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 97 clinical trials were completed, i.e. on average, 72.4% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 65 clinical trials were completed. i.e. 120.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Ohio Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 107 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "GOG Foundation" with 13 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Ohio Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 106 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Biologics, Inc." with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Southern Ohio Medical Center" are "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (10 trials), "Recurrent Breast Carcinoma" (9 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Southern Ohio Medical Center" in a lesser frequency.

Most popular intervention types in "Southern Ohio Medical Center" are "Drug" (167 trials), "Other" (141 trials), "Biological" (92 trials), "Procedure" (52 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (64 trials), "Questionnaire Administration" (36 trials), "Paclitaxel" (31 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Southern Ohio Medical Center" are 159 trials for "All" genders, 56 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Ohio Medical Center". undefined are not yet recruiting, 48 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Southern Ohio Medical Center, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Ohio Medical Center, 9 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Southern Ohio Medical Center has several departments that took part in Clinical trials: "Southern Ohio Medical Center Cancer Center" - 21 trials